PharmaSource: The External Manufacturing Community Your Biopharma Outsourcing Intelligence Hub Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter LATEST NEWS C Ray Therapeutics Obtains First Category C Radiopharmaceutical Manufacturing License Under New NMPA Rules C Ray Therapeutics Obtains First Category C Radiopharmaceutical Manufacturing License Under New NMPA Rules WuXi Biologics Completes First GMP Production at MFG17 Drug Substance Facility Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success ICON Reports $3.3B in Gross Bookings and 1.42x Net Book-to-Bill in Q1 2026 as CRO Backlog Reaches $22.7B CDMO Selection for Small Biotech: Amit Jain on Avoiding Costly Transfers VectorBuilder and MaxCyte Partner to Develop Non-Viral Gene Delivery Platform SK pharmteco Launches SKyvec™ Viral Vector Platform for Gene Therapy Development Wheeler Bio Launches Redesigned Website Highlighting Expanded CDMO Capabilities FamiCord AG Signs Collaboration Agreement with ArThec for Regenerative Medicine Technology Shilpa Biologicals Commissions ADC GMP Manufacturing Facility in Dharwad Shilpa Biologicals Launches PartnerPower Digital Transparency Platform for Biologics Programs WuXi Biologics Completes First GMP Production at MFG17 Drug Substance Facility Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success ICON Reports $3.3B in Gross Bookings and 1.42x Net Book-to-Bill in Q1 2026 as CRO Backlog Reaches $22.7B PODCASTS How Sandoz Cut Its Supplier Network by 34%: A Step-by-Step Consolidation Playbook We’re Joining Life Science Connect: What the PharmaSource and CDMO Live Acquisition Means with Jon Howland, CEO SPOTLIGHT Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success UPCOMING EVENTS External Manufacturing Leaders Basel 2026 CDMO Live Europe 2027 CDMO Live Americas 2026
C Ray Therapeutics Obtains First Category C Radiopharmaceutical Manufacturing License Under New NMPA Rules
C Ray Therapeutics Obtains First Category C Radiopharmaceutical Manufacturing License Under New NMPA Rules
ICON Reports $3.3B in Gross Bookings and 1.42x Net Book-to-Bill in Q1 2026 as CRO Backlog Reaches $22.7B
ICON Reports $3.3B in Gross Bookings and 1.42x Net Book-to-Bill in Q1 2026 as CRO Backlog Reaches $22.7B
We’re Joining Life Science Connect: What the PharmaSource and CDMO Live Acquisition Means with Jon Howland, CEO